Epizyme

Epizyme

World Rank (Jan-05-2024)
18,152
World Rank (Jul-30-2023)
18,152
World Rank (Jan-07-2022)
18,152
Market Cap (Jan-07-2022)
0.234 Billion USD
World Rank (Jan-01-2021)
7,561
Market Cap (Jan-01-2021)
1.103 Billion USD
Headquarters Country
USA
Employee Count
203
Employee Count as of Date
As on 2020
Headquarters City/State
Massachusetts
World Region
Americas
World Subregion
Northern America
Annual Revenue in USD
16 Million USD
Annual Net Income in USD
-232 Million USD
Annual Results for Period Ending
Dec-2020 ending year
Balance Sheet for Period Ending
Dec-2020 ending year
Business Sector
Healthcare
HealthCare Products
Biotechnology
Company Website
EPIZYME INC
Yahoo
Yahoo @ Nasdaq
Company Profile
Epizyme is a Treatment for Cancer and other serious diseases through novel epigenetic medicines company. The company pioneering work in epigenetic drug development is led by the advancement of tazemetostat in a number of cancer indications and treatment settings. The headquarters is in USA.
IPO Year
2013
Stock Exchange
Nasdaq
Frankfurt
Company SubCategory
Top Healthcare Companies in USA

Share